3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Wilms Tumor
2
Prostatic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Germinoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Ependymoma
1
Diabetes Insipidus
1
Carcinoma, Ductal, Breast
1
Breast Carcinoma In Situ
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
pembrolizumab
3
lenvatinib
2
Specimen Handling
2
Nivolumab
2
Cisplatin
2
trastuzumab deruxtecan
1
liposomal doxorubicin
1
fludarabine phosphate
1
fludarabine
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
aldesleukin
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Respiratory Function Tests
1
Radiotherapy
1
Radiation
1
Prochlorperazine
1
Positron-Emission Tomography
1
Platinum
1
Paclitaxel
1
Ondansetron
1
O(6)-codeine methyl ether
1
Nelfinavir
1
Meperidine
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Loperamide
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
Radiotherapy, Conformal
×
90 days
×
Clear all
No trials found.